INS and type 1 diabetes mellitus: The single cell‐type pathology of T1D makes it an attractive candidate for cell replacement therapy and the transplantation of isolated pancreatic islets, which are the only source of primary β cells, offers a long‐term alternative to conventional insulin therapy.